MIDRIXNEO-LUNG Dendritic Cell Vaccine

N/A

Report date: 2024/08/08 20:00:07

Base Information

Drug NameMIDRIXNEO-LUNG Dendritic Cell Vaccine
Drug Alias NameMIDRIXNEO
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGhent University HospitalGhent University
China Registration ClassN/A

Develop Information

Active CompaniesGhent University HospitalGhent University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A